Molecular treatment works against metastatic cancer that spread to the brain
Mount Sinai researchers conducting clinical trials of a drug targeting a cancer gene found that it increased metastatic cancer patients’ survival and was able to work within the brain, according to a study published in Clinical Cancer Research in February. The drug entrectinib targets cancers that involve fusions between the cancer gene NTRK and ... Read More »